Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study
Sabrina Bajwah(King's College London), Magnus Ekström(Lund University), David C. Currow(Cancer Institute of New South Wales), Hanan Tanash(Lund University), Joanna M. Davies(King's College London), Adejoke O Oluyase(King's College London)
Cited by 68
Related Papers
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
Overuse of short-acting β<sub>2</sub>-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
|European Respiratory Journal|2020|447
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
|BMJ|2014|298
Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness
|European Respiratory Journal|2017|298
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|298